Invention Grant
- Patent Title: Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonists
-
Application No.: US16603502Application Date: 2018-04-06
-
Publication No.: US11559537B2Publication Date: 2023-01-24
- Inventor: William W. Bachovchin , Hung-sen Lai , Wengen Wu
- Applicant: Trustees of Tufts College
- Applicant Address: US MA Medford
- Assignee: Trustees of Tufts College
- Current Assignee: Trustees of Tufts College
- Current Assignee Address: US MA Medford
- Agency: Foley Hoag LLP
- Agent Dana M. Gordon; Alexander J. Chatterley
- International Application: PCT/US2018/026470 WO 20180406
- International Announcement: WO2018/187698 WO 20181011
- Main IPC: A61K31/415
- IPC: A61K31/415 ; A61K31/69 ; A61P35/00 ; A61K31/635 ; A61K45/06
Abstract:
Disclosed are combination therapies including administration of Caspase-1 dependent anticancer agents and PGE2 antagonists, and the use of such therapies in the treatment of cell proliferative diseases.
Public/Granted literature
- US20200054655A1 COMBINATION THERAPIES USING CASPASE-1 DEPENDENT ANTICANCER AGENTS AND PGE2 ANTAGONISTS Public/Granted day:2020-02-20
Information query
